The genetics of neonatal respiratory disease

被引:25
作者
Clark, H
Clark, LS
机构
[1] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England
[2] John Radcliffe Hosp, Neonatal Unit, Oxford OX1 3QU, England
[3] Oxford Radcliffe Hosp NHS Trust, Oxford, England
关键词
respiratory distress syndrome (RDS); bronchopulmonary dysplasia; surfactant proteins; SP-A; SP-B; SP-C; SP-D; ABCA3; alveolar proteinosis; transient tachypnoea of the newborn (TTN); cystic fibrosis (CF) screening; primary ciliary dyskinesia (PCD);
D O I
10.1016/j.siny.2005.02.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This chapter reviews some of the genetic predispositions that may govern the presence or severity of neonatal respiratory disorders. Respiratory disease is common in the neonatal period, and genetic factors have been implicated in some rare and common respiratory diseases. Among the most common respiratory diseases are respiratory distress syndrome of the newborn and transient tachypnoea of the newborn, whereas less common ones are cystic fibrosis, congenital alveolar proteinosis and primary ciliary dyskinesias. A common complication of neonatal respiratory distress syndrome is bronchopulmonary dysplasia or neonatal chronic lung disease. This review examines the evidence linking known genetic contributions to these diseases. The value and success of neonatal screening for cystic fibrosis is reviewed, and the recently characterised contribution of polymorphisms and mutations in the surfactant protein genes to neonatal respiratory disease is evaluated. The evidence that known variability in the expression of surfactant protein genes may contribute to the risk of development of neonatal chronic lung disease or bronchopulmonary dysplasia is examined. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 84 条
[1]   Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia [J].
Bartoloni, L ;
Blouin, JL ;
Pan, YZ ;
Gehrig, C ;
Maiti, AK ;
Scamuffa, N ;
Rossier, C ;
Jorissen, M ;
Armengot, M ;
Meeks, M ;
Mitchison, HM ;
Chung, EMK ;
Delozier-Blanchet, CD ;
Craigen, WJ ;
Antonarakis, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10282-10286
[2]   Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants [J].
Beresford, MW ;
Shaw, NJ .
PEDIATRIC RESEARCH, 2003, 53 (04) :663-670
[3]   Lung edema clearance: 20 years of progress - Invited review: Alveolar edema fluid clearance in the injured lung [J].
Berthiaume, Y ;
Folkesson, HG ;
Matthay, MA .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (06) :2207-2213
[4]   Primary ciliary dyskinesia [J].
Bush, A ;
O'Callaghan, C .
ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 87 (05) :363-364
[5]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[6]   EFFECT OF SURFACTANT-ASSOCIATED PROTEIN-A (SP-A) ON THE ACTIVITY OF LIPID EXTRACT SURFACTANT [J].
CHUNG, J ;
YU, SH ;
WHITSETT, JA ;
HARDING, PGR ;
POSSMAYER, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1002 (03) :348-358
[7]   The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema [J].
Clark, H ;
Reid, K .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (11) :981-984
[8]   Collectins and innate immunity in the lung [J].
Clark, HW ;
Reid, KBM ;
Sim, RB .
MICROBES AND INFECTION, 2000, 2 (03) :273-278
[9]   TARGETED DISRUPTION OF THE SURFACTANT PROTEIN-B GENE DISRUPTS SURFACTANT HOMEOSTASIS, CAUSING RESPIRATORY-FAILURE IN NEWBORN MICE [J].
CLARK, JC ;
WERT, SE ;
BACHURSKI, CJ ;
STAHLMAN, MT ;
STRIPP, BR ;
WEAVER, TE ;
WHITSETT, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7794-7798
[10]   PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A ENHANCES THE SURFACE-ACTIVITY OF LIPID EXTRACT SURFACTANT AND REVERSES INHIBITION BY BLOOD PROTEINS INVITRO [J].
COCKSHUTT, AM ;
WEITZ, J ;
POSSMAYER, F .
BIOCHEMISTRY, 1990, 29 (36) :8424-8429